to test drugs that block amyloid plaques from developing in the brains of Alzheimer���s disease patients. Pfizer, Eli Lilly, Bristol-Myers, and Elan and others are racing to test such drugs. This is going on amid much controversy over the true causes of...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to The New York Times Makes Amazing Correction on Alzheimer's Disease Story
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account